Juvise Pharmaceuticals Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 115

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 8

  • Investments
  • 2

Juvise Pharmaceuticals General Information

Description

Manufacturer of pharmaceutical products across various therapeutic areas. The company focuses on acquiring, developing and commercialising as well as offers products related to oncology, gastroenterology, cardiology, rheumatology and neuropsychiatric, thereby providing clients access to a diverse portfolio of specialised medications to meet the needs of patients with various medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 28, rue Bayard
  • 75008 Paris
  • France
+33 04
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 28, rue Bayard
  • 75008 Paris
  • France
+33 04

Juvise Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Juvise Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Juvise Pharmaceuticals‘s full profile, request access.

Request a free trial

Juvise Pharmaceuticals Patents

Juvise Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4415699-A1 Methods of treating multiple sclerosis Inactive 11-Oct-2021
EP-4415712-A1 Methods of treating multiple sclerosis Inactive 11-Oct-2021
AU-2022236428-A1 Pharmaceutical dosage system Pending 17-Mar-2021
EP-4308061-A1 Pharmaceutical dosage system Pending 17-Mar-2021
AU-2018233109-A1 Pharmaceutical combination comprising ponesimod Active 14-Mar-2017 A61K31/277
To view Juvise Pharmaceuticals’s complete patent history, request access »

Juvise Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Juvise Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Juvise Pharmaceuticals‘s full profile, request access.

Request a free trial

Juvise Pharmaceuticals Investments (2)

Juvise Pharmaceuticals’s most recent deal was a Buyout/LBO with Actelion Pharmaceuticals (Global Trade Rights to Ponvory). The deal was made on 26-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Actelion Pharmaceuticals (Global Trade Rights to Ponvory) 26-Mar-2024 Buyout/LBO Buildings and Property
AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) 20-Dec-2019 Corporate Asset Purchase Buildings and Property
To view Juvise Pharmaceuticals’s complete investments history, request access »

Juvise Pharmaceuticals FAQs

  • When was Juvise Pharmaceuticals founded?

    Juvise Pharmaceuticals was founded in 2008.

  • Where is Juvise Pharmaceuticals headquartered?

    Juvise Pharmaceuticals is headquartered in Paris, France.

  • What is the size of Juvise Pharmaceuticals?

    Juvise Pharmaceuticals has 115 total employees.

  • What industry is Juvise Pharmaceuticals in?

    Juvise Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Juvise Pharmaceuticals a private or public company?

    Juvise Pharmaceuticals is a Private company.

  • What is Juvise Pharmaceuticals’s current revenue?

    The current revenue for Juvise Pharmaceuticals is .

  • How much funding has Juvise Pharmaceuticals raised over time?

    Juvise Pharmaceuticals has raised $886M.

  • Who are Juvise Pharmaceuticals’s investors?

    Bpifrance, Pemberton Asset Management, and CIC Private Debt have invested in Juvise Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process